Literature DB >> 8923946

Prenatal ultrasonographic findings of dominant polycystic kidney disease and postnatal renal evolution.

D Sinibaldi1, S Malena, R Mingarelli, G Rizzoni.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a relatively common genetic disorder, and its prenatal diagnosis has been reported with increasing frequency. Nevertheless, no data are available on the significance of prenatal ultrasound (US) patterns in predicting postnatal renal function and outcome. We report on one case of ADPKD diagnosed prenatally by US, and on two cases diagnosed immediately after birth, with different prenatal US and renal outcomes. Data on prenatal US findings and postnatal renal evolution are scanty and largely incomplete. Apparently, none of the prenatal findings are consistently different in cases with and without normal postnatal renal function and blood pressure. More complete information on prenatal US findings and postnatal renal evolution is urgently needed.

Entities:  

Mesh:

Year:  1996        PMID: 8923946     DOI: 10.1002/(SICI)1096-8628(19961111)65:4<337::AID-AJMG17>3.0.CO;2-V

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  3 in total

Review 1.  Prenatal diagnosis of autosomal dominant polycystic kidney disease (PKD1) presenting in utero and prognosis for very early onset disease.

Authors:  K D MacDermot; A K Saggar-Malik; D L Economides; S Jeffery
Journal:  J Med Genet       Date:  1998-01       Impact factor: 6.318

2.  Prognosis of autosomal dominant polycystic kidney disease diagnosed in utero or at birth.

Authors:  Olivia Boyer; Marie-France Gagnadoux; Geneviève Guest; Nathalie Biebuyck; Marina Charbit; Rémi Salomon; Patrick Niaudet
Journal:  Pediatr Nephrol       Date:  2006-11-24       Impact factor: 3.714

3.  Which Stage of ADPKD Is More Appropriate for Decortication? A Retrospective Study of 137 Patients from a Single Clinic.

Authors:  Xiaoqiang Qian; Xujun Sheng; Ruipeng Li; Hailong Liu; Xiangjie Kong; Liujian Duan; Jun Qi
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.